CG Oncology (CGON) Accumulated Depreciation (2024 - 2026)

CG Oncology has reported Accumulated Depreciation for 3 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation changed N/A year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (changed N/A YoY), and the FY2025 full-year result was $1.5 million, up 1594.25% from the prior year.
• Accumulated Depreciation for Q1 2026 stood at $2.3 million, up from $1.5 million in the prior quarter.
• The five-year high for Accumulated Depreciation was $2.3 million in Q1 2026, with the low at $87000.0 in Q4 2024.
• Historically, Accumulated Depreciation has averaged $1.1 million across 3 years, with a median of $1.0 million in 2025.
• The largest YoY upside for Accumulated Depreciation was 1594.25% in 2025 against a maximum downside of 1594.25% in 2025.
• CG Oncology's Accumulated Depreciation stood at $87000.0 in 2024, then soared by 1594.25% to $1.5 million in 2025, then jumped by 55.63% to $2.3 million in 2026.
• The last three Accumulated Depreciation figures came in at $2.3 million (Q1 2026), $1.5 million (Q4 2025), and $623000.0 (Q3 2025), per Business Quant data.